The turbulences of serum oxidative stress factors (SOD, MDA) and cytokine (TNF-α, INF-γ, IL-1β, IL-4, and IL-6) were regulated by RA treatment, suggesting RA could protect against oxidative stress and low-grade inflammation in T2D. The gene discussed is SOD1; the disease is type 2 diabetes mellitus.